Magellan Health, Inc. (MGLN): Price and Financial Metrics


Magellan Health, Inc. (MGLN)

Today's Latest Price: $44.06 USD

1.84 (-4.01%)

Updated Mar 27 12:00am

Add MGLN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 9 in Medical - Health Insurance

See all "A" rated Strong Buy stocks

MGLN Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MGLN is 5.12 -- better than 91.88% of US stocks.
  • Of note is the ratio of Magellan Health Inc's sales and general administrative expense to its total operating expenses; merely 0.32% of US stocks have a lower such ratio.
  • With a price/sales ratio of 0.13, Magellan Health Inc has a higher such ratio than merely 8.87% of stocks in our set.
  • Stocks that are quantitatively similar to MGLN, based on their financial statements, market capitalization, and price volatility, are JBGS, AEMD, IPG, VVI, and TRNO.
  • MGLN's SEC filings can be seen here. And to visit Magellan Health Inc's official web site, go to www.magellanhealth.com.
MGLN Daily Price Range
MGLN 52-Week Price Range

MGLN Stock Price Chart More Charts


MGLN Price/Volume Stats

Current price $44.06 52-week high $81.04
Prev. close $45.90 52-week low $30.60
Day low $41.51 Volume 199,000
Day high $46.67 Avg. volume 190,613
50-day MA $62.78 Dividend yield N/A
200-day MA $67.35 Market Cap 1.09B

Magellan Health, Inc. (MGLN) Company Bio


Magellan Health provides services to health plans, managed care organizations (MCOs), employers, labor unions, military and governmental agencies, third party administrators, consultants and brokers. Its business is divided into five segments, which include managed healthcare, specialty solutions and pharmacy management. The company was founded in 1969 and is based in Scottsdale, Arizona.

MGLN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$44.06$9.14-80%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Magellan Health Inc. To summarize, we found that Magellan Health Inc ranked in the 14th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Magellan Health Inc ended up being:

  • The company's balance sheet shows it gets 62% of its capital from equity, and 38% of its capital from debt. Its equity weight surpasses that of merely 21.45% of free cash flow generating stocks in the Healthcare sector.
  • The company's compound free cash flow growth rate over the past 5.84 years comes in at -0.16%; that's greater than only 12.18% of US stocks we're applying DCF forecasting to.
  • Magellan Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 18 -- greater than 70.62% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-80%
1%-80%
2%-80%
3%-80%
4%-80%
5%-80%

Want more companies with a valuation profile/forecast similar to that of Magellan Health Inc? See HAE, IDXX, RMD, GMED, and QGEN.


MGLN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

MGLN Latest Social Stream


Loading social stream, please wait...

View Full MGLN Social Stream

MGLN Price Returns

1-mo -26.58%
3-mo -43.42%
6-mo -27.29%
1-year -33.16%
3-year -36.33%
5-year -37.79%
YTD -43.69%
2019 37.55%
2018 -41.08%
2017 28.31%
2016 22.04%
2015 2.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7562 seconds.